Organophosphorus poisoning and anaesthesia

Area of Science:

• Toxicology
• Neuroscience
• Environmental Health

Background:

• Organophosphorus compounds are widely used as insecticides and chemical warfare agents, posing significant global health risks.
• Exposure can lead to acute cholinergic crisis, intermediate syndrome, and delayed polyneuropathy.
• Additional health impacts include thermoregulatory, endocrine, immune, and reproductive dysfunction, as well as cardiac and neuropsychiatric disorders.

Purpose of the Study:

• To review the multifaceted health problems associated with organophosphorus compound exposure.
• To highlight the limitations of current treatments and the need for novel therapeutic strategies.
• To emphasize the necessity of collaborative research for accurate information dissemination.

Main Methods:

• Literature review of clinical entities and reported disorders following organophosphorus compound exposure.
• Discussion of drug sensitivities and altered neuromuscular blockade responses.
• Exploration of potential therapeutic agents from animal studies.

Main Results:

• Organophosphorus compounds cause distinct clinical syndromes and a broad spectrum of systemic health disturbances.
• Inhibition of cholinesterases leads to altered drug responses, particularly concerning neuromuscular blockers.
• Established treatments (oximes, atropine) have not adequately reduced poisoning morbidity and mortality.

Conclusions:

• There is an urgent need for improved understanding and management of organophosphorus compound toxicity.
• Novel therapeutic agents showing promise in animal models warrant further investigation.
• International collaboration is crucial to address the significant health burden of these compounds, especially in developing countries.